Juergen E. Gschwend

Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer

Matthias Eiber, Gregor Weirich, Konstantin Holzapfel et al. · European Urology · 2016 · 567 citations

Engineering, Oncologic Imaging, Medical Imaging +11

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

Sven Perner, Matthias D. Hofer, Robert Kim et al. · Human Pathology · 2007 · 457 citations

Urology, Perineural Invasion, Genitourinary Cancer +6

Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer

Jutta Engel, Patrick J. Bastian, H. Baur et al. · European Urology · 2010 · 262 citations

Urology, Surgical Oncology, Medicine +6

Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer

Rainer Kuefer, Matthias D. Hofer, Vedat Altug et al. · British Journal of Cancer · 2004 · 152 citations · Full text

Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial

Daniel P. Petrylak, Nicholas J. Vogelzang, Nikolay Budnik et al. · The Lancet Oncology · 2015 · 147 citations

Urology, Placebo-controlled Phase 3, Genitourinary Cancer +7